The Source for Neurovascular News and Education

May 16, 2024

 

Decision-making should be based on prognostic evaluation, researchers say.

 

Patients with impaired cognitive or physical functioning prior to experiencing a stroke may still be good candidates for an endovascular intervention, according to an analysis of the MR CLEAN registry published online September 11, 2018, ahead of print in Stroke.

 

“In recently reported trials which led to the implementation of endovascular treatment for stroke, only a few patients were included who were functionally dependent before the current stroke,” lead author Robert-Jan B. Goldhoorn, MD (Maastricht University Medical Center, the Netherlands), told Neurovascular Exchange. In addition, thrombectomy registries have yet to report on outcome of prestroke-dependent patients, so very little is known about their outcomes.

 

Lacking evidence-based guidance on how to treat prestroke-dependent patients, currently “some patients would be given the benefit of the doubt on the basis of individual favorable characteristics” and treated endovascularly, he indicated.

 

Goldhoorn and colleagues analyzed outcomes of 1,441 patients who underwent endovascular treatment of anterior circulation stroke and who were included in the MR CLEAN registry between March 2014 and June 2016. Among these patients, they identified 157 (11%) as prestroke dependent, meaning they had an mRS score of 3-5 prior to the index stroke.

 

Among the prestroke-dependent patients, 27% had a favorable outcome, defined as a 90-day mRS 0-2 or no worsening of the mRS score from the time prior to the index stroke. In comparison, 42% of the patients who were prestroke independent had a favorable outcome (P < 0.05).

 

Not a Predictor of Unfavorable Outcome

 

After adjusting for age, baseline National Institutes of Health Stroke Scale score, collaterals, time to endovascular intervention, and use of intravenous thrombolysis before the intervention, prestroke dependence was not a predictor of having a less favorable outcome (adjusted OR 0.90; 95% CI 0.58-1.39). The occurrence of symptomatic intracranial hemorrhage and ischemic stroke progression was similar in both groups.

 

Based on these findings, prestroke-dependent patients should not be excluded from endovascular interventions out of hand, concluded Goldhoorn. “In prestroke-dependent patients in whom successful reperfusion was achieved, the mortality rate was lower and the rate of favorable outcome was slightly higher, compared to unsuccessfully reperfused patients,” he noted. Their mortality rate is high, but the risk of treatment-related complications is not elevated.

 

The decision to go ahead with an endovascular intervention should be made with caution, he recommended. “Patients should be selected on the basis of the prognosis of preexistent disease and expected extent of the burden from the current neurological deficit on top of the preexistent deficit.”

 

Unanswered questions remain that can only be addressed by a randomized trial, he acknowledged, including the issues of selection bias and treatment effect.

 


Source:

Goldhoorn RJB, Verhagen M, Diederik, Dippel DWJ, et al, et al. Safety and outcome of endovascular treatment in prestroke-dependent patients results from MR CLEAN registry. Stroke. 2018;Epub ahead of print.

 

Disclosures:

Goldhoorn reports no relevant conflicts of interest.

 

 

 

Monday, October 26 2020

Stroke rates for the balloon-expandable device far exceeded those of the Evolut R; conscious...

Read More »

Monday, October 26 2020

Safety goals were met in the trial, but better efficacy may require ensuring complete coverage of...

Read More »

Wednesday, September 23 2020

The findings “reinforce that this is absolutely the right thing to do and that we need to set up...

Read More »

Tuesday, July 21 2020

Whether COVID-19 adds risk by virtue of being a comorbidity or due to direct effects is unknown. A...

Read More »

Friday, May 8 2020

In some cases, large strokes are the first presentation of COVID-19 in younger patients, but...

Read More »

Monday, April 6 2020

Clopidogrel added to rivaroxaban and aspirin increased bleeding with no added protection from limb or...

Read More »

Monday, April 6 2020

Although rivaroxaban patients had more bleeding, the events were not severe and none were...

Read More »

Monday, April 6 2020

The strokes do not appear related to valve thrombosis or structural degeneration, but rather to...

Read More »

Thursday, January 23 2020

A fundamental unanswered question is whether any type of oral anticoagulation is needed in the...

Read More »

Monday, January 6 2020

Though periprocedural results look good, there are some questions about its rapid rise when...

Read More »

Wednesday, August 21 2019

In addition, an infarct in a new territory did not emerge as an independent predictor of...

Read More »

Wednesday, August 21 2019

The procedure—a hybrid of surgical and endovascular techniques—offers low stroke rates and a short...

Read More »